Expression of ANO1/DOG1 is associated with shorter survival and progression of breast carcinomas
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Bae, Jun Sang | - |
dc.contributor.author | Park, Jeong Yeol | - |
dc.contributor.author | Park, See-Hyoung | - |
dc.contributor.author | Ha, Sang Hoon | - |
dc.contributor.author | An, Ae Ri | - |
dc.contributor.author | Noh, Sang Jae | - |
dc.contributor.author | Kwon, Keun Sang | - |
dc.contributor.author | Jung, Sung Hoo | - |
dc.contributor.author | Park, Ho Sung | - |
dc.contributor.author | Kang, Myoung Jae | - |
dc.contributor.author | Jang, Kyu Yun | - |
dc.date.available | 2020-07-10T04:30:55Z | - |
dc.date.created | 2020-07-06 | - |
dc.date.issued | 2018-01-02 | - |
dc.identifier.issn | 1949-2553 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hongik/handle/2020.sw.hongik/4108 | - |
dc.description.abstract | The expression of ANO1 is considered to have diagnostic specificity for gastrointestinal stromal tumors. However, its function as a calcium-activated chloride channel suggests that the expression of ANO1 is not restricted to gastrointestinal stromal tumors. Recently, it has been reported that ANO1 has roles in the progression of human malignant tumors. However, the role of ANO1 in breast carcinoma has been controversial. Therefore, we investigated the expression of ANO1 in 139 breast carcinoma patients and the role of ANO1 in vitro. The immunohistochemical expression of ANO1 was significantly associated with the expression of beta-catenin, cyclin D1, MMP9, snail, and E-cadherin. Especially, ANO1 expression was an independent indicator of poor prognosis of shorter overall survival and relapse-free survival of breast carcinoma patients by multivariate analysis. In MCF7 and MDA-MB-231 breast carcinoma cells, inhibition of ANO1 with T16Ainh-A01 or siRNA for ANO1 significantly suppressed the proliferation of cells. Knock-down of ANO1 with siRNA induced G0/G1 cell cycle arrest and significantly inhibited the invasiveness of breast carcinoma cells. Knock-down of ANO1 decreased the expression of beta-catenin, cyclin D1, MMP9, snail, and N-cadherin, and increased the expression of E-cadherin. In conclusion, this study demonstrates that ANO1 expression is an indicator of poor prognosis of breast carcinoma patients and suggests that ANO1 might be a therapeutic target for breast carcinoma patients with ANO1-positive tumors and poor prognosis. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | IMPACT JOURNALS LLC | - |
dc.subject | CA2+-ACTIVATED CL-CHANNEL | - |
dc.subject | ACTIVATED CHLORIDE CHANNEL | - |
dc.subject | SQUAMOUS-CELL CARCINOMA | - |
dc.subject | HEPATOCELLULAR-CARCINOMA | - |
dc.subject | TMEM16A EXPRESSION | - |
dc.subject | CANCER PROGRESSION | - |
dc.subject | GASTRIC-CANCER | - |
dc.subject | GROWTH-FACTOR | - |
dc.subject | ANO1 TMEM16A | - |
dc.subject | TUMOR-GROWTH | - |
dc.title | Expression of ANO1/DOG1 is associated with shorter survival and progression of breast carcinomas | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Park, See-Hyoung | - |
dc.identifier.doi | 10.18632/oncotarget.23078 | - |
dc.identifier.scopusid | 2-s2.0-85040637502 | - |
dc.identifier.wosid | 000419615500049 | - |
dc.identifier.bibliographicCitation | ONCOTARGET, v.9, no.1, pp.607 - 621 | - |
dc.relation.isPartOf | ONCOTARGET | - |
dc.citation.title | ONCOTARGET | - |
dc.citation.volume | 9 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 607 | - |
dc.citation.endPage | 621 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.subject.keywordPlus | CA2+-ACTIVATED CL-CHANNEL | - |
dc.subject.keywordPlus | ACTIVATED CHLORIDE CHANNEL | - |
dc.subject.keywordPlus | SQUAMOUS-CELL CARCINOMA | - |
dc.subject.keywordPlus | HEPATOCELLULAR-CARCINOMA | - |
dc.subject.keywordPlus | TMEM16A EXPRESSION | - |
dc.subject.keywordPlus | CANCER PROGRESSION | - |
dc.subject.keywordPlus | GASTRIC-CANCER | - |
dc.subject.keywordPlus | GROWTH-FACTOR | - |
dc.subject.keywordPlus | ANO1 TMEM16A | - |
dc.subject.keywordPlus | TUMOR-GROWTH | - |
dc.subject.keywordAuthor | breast | - |
dc.subject.keywordAuthor | carcinoma | - |
dc.subject.keywordAuthor | ANO1 | - |
dc.subject.keywordAuthor | DOG1 | - |
dc.subject.keywordAuthor | prognosis | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
94, Wausan-ro, Mapo-gu, Seoul, 04066, Korea02-320-1314
COPYRIGHT 2020 HONGIK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.